More freedom every day

Every MiniMed system is built to take on more of the work of diabetes, so you do less. 

MiniMed Flex system

Freedom to manage your way

MiniMed FlexTM system
Automated insulin pump therapy

MiniMed Flex system, Phone, Instinct sensor lighter

Freedom at mealtimes

Not a perfect carb counter or sometimes forget to bolus? It's OK. The system's Meal DetectionTM technology is there to help keep your levels in range.†.‡

Freedom to wear your way§

Small, sleek, and designed to stay tucked away all day while you deliver boluses and check your numbers from a phone. Available on iOS and Android.

Freedom from daily injections

Designed for once-a-week◊ changes and charging.

  • Multiple infusion set options, including a 7-day infusion set — that means 96% fewer injections than traditional insulin shots.
  • Easy-to-insert sensor options, including the 15-day Instinct sensor, made by Abbott, or the Simplera SyncTM sensor.

Learn more

MiniMed GoTM system
Smart insulin pen therapy

MiniMed Go- Instinct and InPen

Remembers your doses

Automatically records prior doses in the app so there's less to keep track of.


Reminds you when to act

Alerts you when more insulin is needed to keep levels in range — no unnecessary notifications.#, 1


Recommends your dose 

Calculates the right dose for meals and corrections, factoring in glucose, active insulin, and missed doses to help prevent lows.

Learn more

Customize your system

Choose the level of support that's right for you, including options of easy-to-use sensors and a connected digital experience.

Get started

Product interest request form

Please complete the items below so that we may provide you helpful information regarding our diabetes therapies.

indicates a required field.

Have you ever used a MiniMed therapy?
This field is required.
*
This field is required.
This field is required.
*
This field is required.
This field is required.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:

Sign-up to receive our newsletter for monthly updates and tips
Visit our blog to read helpful diabetes stories and perspective from the community

If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:

Sign-up to receive our newsletter for monthly updates and tips
Visit our blog to read helpful diabetes stories and perspective from the community

If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.

This form is for customers in the Unites States only. For more information about our products in your region please see our list of international locations.

This field is required.

By checking this box, I agree to receive promotional SMS messages from MiniMed at the mobile number provided. Message frequency varies. Message and data rates may apply. Reply STOP to opt out or HELP for support. Consent is not a condition of purchase. View our Privacy Policy and Terms & Conditions.

HIPAA Marketing Authorization

MiniMed respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors who are assisting us with these activities.

I understand that this Authorization may permit MiniMed to contact me by text message, telephone, or email. With respect to text messages, I consent to receiving text messages at the phone number(s) submitted using automated technology from or on behalf of MiniMed, concerning the marketing, advertising, and/or offers of sale of MiniMed products, therapies, and services. I also certify that I am (a) age 18 or older and (b) authorizing and consenting to use of the information provided for MiniMed to contact me. My consent is not a condition for purchase. Airtime, message, and data rates may apply. I may opt out at any time by (i) texting "STOP" in reply to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into my MiniMed myHome profile and updating my communication preferences (www.diabetes.shop/communication).

Please note that this Authorization is optional, and you may refuse to opt in. If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLink™ Personal system, or other MiniMed products, mobile apps, or services.

This Authorization will expire ten (10) years from the date you submit it online. You may revoke it by:

Opting out will not affect actions already taken. Information disclosed may be re-disclosed and no longer protected by federal privacy standards. Questions? Contact Customer Service at 800-646-4633 or takecontrol@medtronic.com.
This field is required.

The MiniMed Difference

For over 40 years, we've been a trusted partner in the diabetes community. Our innovation and support help people around the world do less work, and have more freedom.

Advanced insulin delivery

Our automated insulin delivery and smart dosing systems are designed to give more peace of mind and reduce diabetes burden.

MiniMed Go home screen & InPen

Getting started, simplified

We make it easy to try new technology with an intuitive, guided experience that helps you start with confidence and ease.

Woman with Flex, Simplera sensor and smoothie, Simplera and smoothie

Building the hands-free future

We're leading the way in building what's next, with a goal of providing technology that can handle diabetes management on its own.

Footnotes

† Refers to SmartGuardTM feature. Individual results may vary. 
‡ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Do not wear or place your pump more than 14 in (35.5 cm) above your infusion site. Doing so can cause an over-delivery of insulin, which may result in hypoglycemia
¶ Assumes 4 injections per day for 30 days and one infusion set change every seven days.
◊ Assumes one infusion set every seven days. More insertions may be required if the Extended infusion set requires replacement before specified wear time.
# Proper pairing, connectivity, and settings required. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.

References

1. Why CGM alone is not enough: low actionability of CGM alerts without considering impact of active insulin. M.B. Smith, G. Im, J. MacLeod, R.A. Vigersky; Abstract #758. 59th annual EASD meeting 5 Oct 2023. (actionability of CGM alerts)

Important Safety Information: MiniMed FlexTM system with SmartGuardTM technology with Simplera SyncTM sensor and Instinct sensor

The MiniMed FlexTM system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. 

The MiniMed FlexTM system includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system.  Discuss treatment decisions with your HCP. 

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.  

WARNING: Do not use the MiniMedTM Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMedTM Flex system. 

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia. 

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed FlexTM system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks.

 

©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.

Important safety information: MiniMed Go system

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.